Literature DB >> 15223095

The effect of relapse on cognition in abstinent methamphetamine abusers.

Sara L Simon1, Jennifer Dacey, Susan Glynn, Richard Rawson, Walter Ling.   

Abstract

Data from 75 participants in a longitudinal study of methamphetamine (MA) abuse were used to differentiate the cognitive performance of those who remained abstinent, relapsed, or continued to use during treatment. Participants were divided into three groups: continuous abstinence, initial abstinence but relapse, and continuous use. Groups did not differ on age, education, gender or ethnicity. Participants in the longitudinal study completed a battery of cognitive tests within 7 days of their last use of MA, then were re-tested monthly for up to 6 months (average time for this analysis was 92 days). For episodic memory, the relapse groups performance was worse than the abstinent and significantly worse than that of the continued use group who had the best performance on all measures. Relapse to methamphetamine use may affect episodic memory differently than it affects the other cognitive functions measured.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15223095     DOI: 10.1016/j.jsat.2004.03.011

Source DB:  PubMed          Journal:  J Subst Abuse Treat        ISSN: 0740-5472


  44 in total

Review 1.  The need for speed: an update on methamphetamine addiction.

Authors:  Alasdair M Barr; William J Panenka; G William MacEwan; Allen E Thornton; Donna J Lang; William G Honer; Tania Lecomte
Journal:  J Psychiatry Neurosci       Date:  2006-09       Impact factor: 6.186

2.  Visual memory in methamphetamine-dependent individuals: deficient strategic control of encoding and retrieval.

Authors:  Erin E Morgan; Steven P Woods; Amelia J Poquette; Ofilio Vigil; Robert K Heaton; Igor Grant
Journal:  Aust N Z J Psychiatry       Date:  2012-02       Impact factor: 5.744

Review 3.  Neurocognitive effects of methamphetamine: a critical review and meta-analysis.

Authors:  J Cobb Scott; Steven Paul Woods; Georg E Matt; Rachel A Meyer; Robert K Heaton; J Hampton Atkinson; Igor Grant
Journal:  Neuropsychol Rev       Date:  2007-09       Impact factor: 7.444

4.  Poor working memory and reduced blood pressure levels in concurrent users of khat and tobacco.

Authors:  Motohiro Nakajima; Richard Hoffman; Mustafa Al'Absi
Journal:  Nicotine Tob Res       Date:  2013-09-28       Impact factor: 4.244

5.  Modafinil restores methamphetamine induced object-in-place memory deficits in rats independent of glutamate N-methyl-D-aspartate receptor expression.

Authors:  Carmela M Reichel; Meghin G Gilstrap; Lauren A Ramsey; Ronald E See
Journal:  Drug Alcohol Depend       Date:  2013-09-27       Impact factor: 4.492

6.  Denial in methamphetamine users: Associations with cognition and functional connectivity in brain.

Authors:  Andy C Dean; Milky Kohno; Angelica M Morales; Dara G Ghahremani; Edythe D London
Journal:  Drug Alcohol Depend       Date:  2015-03-18       Impact factor: 4.492

7.  Educational attainment is not a good proxy for cognitive function in methamphetamine dependence.

Authors:  Andy C Dean; Gerhard Hellemann; Catherine A Sugar; Edythe D London
Journal:  Drug Alcohol Depend       Date:  2011-12-27       Impact factor: 4.492

8.  Striatum and insula dysfunction during reinforcement learning differentiates abstinent and relapsed methamphetamine-dependent individuals.

Authors:  Jennifer L Stewart; Colm G Connolly; April C May; Susan F Tapert; Marc Wittmann; Martin P Paulus
Journal:  Addiction       Date:  2013-12-15       Impact factor: 6.526

Review 9.  Chronic methamphetamine self-administration disrupts cortical control of cognition.

Authors:  Aurelien Bernheim; Ronald E See; Carmela M Reichel
Journal:  Neurosci Biobehav Rev       Date:  2016-07-20       Impact factor: 8.989

10.  How long does craving predict use of methamphetamine? Assessment of use one to seven weeks after the assessment of craving: Craving and ongoing methamphetamine use.

Authors:  Gantt P Galloway; Edward G Singleton
Journal:  Subst Abuse       Date:  2009-08-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.